Dextromethorphan and guaifenesin use needs to be monitored cautiously in patients with "weak metabolizer" CYP2D6 enzyme amounts and patients who're sedated. This combination medication has a big median toxic dose (TD50) to median productive dose (ED50) ratio (or therapeutic index) in these individuals. However, if your signs or symptoms are https://socialbaskets.com/story3646067/5-simple-statements-about-dextromethorphan-dxm-for-sale-in-copyright-explained